相关实验视频
Updated: Jun 25, 2025

08:28
Experimental Metastasis Assay
Published on: August 24, 2010
20.3K
从瘤到骨:生长因子受体作为癌症转移的关键参与者
Khalid Said Mohammad1, Shahid Akhtar Akhund1
1Department of Anatomy, College of Medicine, Alfaisal University, 1153 Riyadh, Saudi Arabia.
Frontiers in bioscience (Landmark edition)
|May 30, 2024
概括
增长因子及其受体在乳腺癌和前列腺癌等癌症中驱动骨转移. 针对这些途径,通过破坏瘤生长和骨质退化,为骨癌提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨转移是各种癌症的重要并发症,包括乳腺癌,前列腺癌,肺癌和癌.
- 生长因子及其受体在癌症进展和骨微观环境中发挥着关键作用.
研究的目的:
- 审查生长因子和骨转移之间的复杂相关性.
- 要突出关键生长因子受体 (EGFR,TGFβ,VEGFR,FGFR) 在骨转移的发展和进展中的作用.
- 探索针对骨转移的有针对性的治疗策略.
主要方法:
- 对骨转移中生长因子受体的临床前和临床研究的文献综述.
- 对参与瘤与骨相互作用的信号通路的分析.
- 检查向疗法及其作用机制.
主要成果:
- 在乳腺癌和肺癌中,EGFR信号促进骨质细胞发育和骨质溶解性病变.
- TGFβ受体有助于骨解和骨质细胞转移,特别是在前列腺癌中.
- FGFR和VEGFR分别参与骨形成和瘤血管生成.
结论:
- 针对生长因子受体通路 (VEGF/VEGFR,EGF/EGFR,FGF/FGFR,TGFβ/TGFβR) 提供了有前途的治疗途径.
- 了解瘤与骨微环境的相互作用对于开发有效的治疗方法至关重要.
- 向治疗,包括小分子抑制剂和单克隆抗体,显示在管理骨转移的潜力.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

